ArticleEMBO molecular medicine2019

Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.

Huanhuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.